The global VEGF Targeted Drugs for Breast Cancer market size was valued at US$ 1.67 billion in 2024 and is projected to reach US$ 2.45 billion by 2030, at a CAGR of 6.6% during the forecast period 2024-2030. United States VEGF Targeted Drugs for Breast Cancer market size was valued at US$ 789 million in 2024 and is projected to US$ 1.14 billion by 2030, at a CAGR of 6.3% during the forecast peri..
